李淑娟
摘??要:目的:探究將冰硼散聯(lián)合思密達(dá)應(yīng)用于復(fù)發(fā)性口腔潰瘍患者治療中的效果,分析其臨床可應(yīng)用價(jià)值。方法:選擇2018年10月--2020年8月作為研究時(shí)段,在該時(shí)段將86名復(fù)發(fā)性口腔潰瘍患者作為研究對(duì)象,在獲得患者一般資料后按照控制變量原則對(duì)患者進(jìn)行隨機(jī)兩組均分,分別記名為對(duì)照組與實(shí)驗(yàn)組,組內(nèi)樣本量設(shè)置為43。對(duì)照組患者選擇冰硼散進(jìn)行治療,實(shí)驗(yàn)組患者在冰硼散的基礎(chǔ)上配合思密達(dá)進(jìn)行治療,對(duì)兩組患者的炎癥指標(biāo)進(jìn)行記錄,同時(shí)記錄患者的治療總有效率,評(píng)估患者在治療完成后的口腔潰瘍恢復(fù)狀況,分析組間差異。結(jié)果:實(shí)驗(yàn)結(jié)果顯示,相較于對(duì)照組來(lái)說(shuō),實(shí)驗(yàn)組患者的各項(xiàng)炎癥指標(biāo)數(shù)據(jù)明顯更低,提示實(shí)驗(yàn)組患者體內(nèi)的炎癥狀況得到有效的控制,組間差異顯著(P<0.05)。而在實(shí)驗(yàn)結(jié)果中發(fā)現(xiàn),相較于對(duì)照組來(lái)說(shuō),實(shí)驗(yàn)組患者的治療總有效率明顯更高,組內(nèi)數(shù)據(jù)對(duì)比差異顯著(P<0.05)。結(jié)論:在對(duì)復(fù)發(fā)性口腔潰瘍患者進(jìn)行治療時(shí),將冰硼散聯(lián)合思密達(dá)應(yīng)用于患者的治療中有助于改善患者的病情,一方面來(lái)說(shuō),能夠使患者的治療效果得到提升,另一方面還能夠最大限度的提高患者的整體生活質(zhì)量并且這種治療方案能夠消除患者體內(nèi)炎癥,具有良好的可應(yīng)用價(jià)值,值得推廣使用。
關(guān)鍵詞:冰硼散;思密達(dá);復(fù)發(fā)性口腔潰瘍;炎癥因子分析
Abstract:?To?explore?the?effect?of?bingbosan?combined?with?Smecta?in?the?treatment?of?recurrent?oral?ulcer?and?analyze?its?clinical?value.?Methods:?86?patients?with?recurrent?oral?ulcer?were?selected?as?the?study?period?from?October?2018?to?August?2020.?After?obtaining?the?general?data?of?patients,?the?patients?were?randomly?divided?into?two?groups?according?to?the?control?variable?principle.?The?patients?were?divided?into?control?group?and?experimental?group?respectively,?and?the?sample?size?was?set?to?43.?The?control?group?patients?chose?bingboron?powder?for?treatment.?The?experimental?group?patients?treated?with?Smecta?on?the?basis?of?bingbosan,?recorded?the?inflammatory?indexes?of?the?two?groups,?recorded?the?total?effective?rate?of?the?treatment,?evaluated?the?recovery?of?the?patients'?oral?ulcer?after?the?treatment,?analysis?of?the?differences?between?the?groups.?Results:?the?results?showed?that?the?data?of?inflammatory?indexes?in?the?experimental?group?were?significantly?lower?than?that?of?the?control?group,?suggesting?that?the?inflammation?status?in?the?experimental?group?was?effectively?controlled,?and?the?difference?between?the?groups?was?significant?(P?0.05).?The?results?showed?that?the?total?effective?rate?of?treatment?in?the?experimental?group?was?significantly?higher?than?that?of?the?control?group,?and?the?difference?of?data?in?the?group?was?significant?(P?0.05).?Compared?with?the?control?group,?the?pain?score,?quality?of?life?score?and?masticatory?function?score?of?the?experimental?group?were?significantly?better?than?those?in?the?control?group,?and?the?difference?between?the?two?groups?was?significant?(P?0.05).?Conclusion:?in?the?treatment?of?recurrent?oral?ulcer,?the?combination?of?bingbosan?and?Smecta?can?improve?the?patients'?condition.?On?the?one?hand,?it?can?improve?the?treatment?effect?of?patients,?on?the?other?hand,?it?can?also?maximize?the?overall?quality?of?life?of?patients?and?the?treatment?can?eliminate?inflammation?in?patients,?which?has?good?performance?The?application?value?of?the?product?is?worth?popularizing.